The Canada minimally invasive surgery devices market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing prevalence of lifestyle-related and chronic disorders activities in the country.
Minimally invasive surgery, also known as minimally invasive procedures, are utilized to treat medical conditions such as spinal and dental procedures, cardiac procedures, and aneurysms. These devices come with improvements in fiber-optics and image guidance. They also include enhancements in software systems and robotic components and are increasingly preferred in the healthcare industry. For example, video-assisted thoracoscopic surgery (VATS), is performed for completely removing an organ to treat trauma injuries.
Food and Drug Administration Act (FDA) manages the minimally invasive surgical devices market in Canada and the US. The organizations manufacturing robotic minimally invasive surgical devices have to list down any available possibility to health. In December 2019, FDA delivered a wellbeing similarity respecting the alert when using robotically-assisted minimally invasive surgical devices in women's health including mastectomy and other cancer-related surgeries. However, the FDA is worried about the medical services suppliers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or therapy of cancer.
Market Trends, Drivers, Restraints and Opportunities
- Increasing development of minimally invasive procedures is expected to boost the medical devices market.
- Rising demand for surgical procedures that are less painful are key factors fueling the market growth.
- Growing incidence of cardiovascular diseases is estimated to accelerate the growth of the market.
- Rapid adoption of technological advancements in the field of medical equipment is one of the major factors driving the market growth.
- High installation cost can restrain the growth of the market.
- Government initiatives to control the cardiovascular diseases and policies in favor of the industry is estimated to foster the market growth.
Scope of the Report
The report on the Canada minimally invasive surgery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Minimally Invasive Surgery Devices Market - Canada Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Products (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Endoscopic Devices, Laproscopic Devices, Robotic Assisted Surgical Systems, Ablation Devices, Laser Based Devices, and Others), and Applications (Aesthetic, Cardiovascular, Gastrointestinal, Gynecological, Orthopedic, Urological, and Others)
|
|
Country Scope
|
Canada
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast.
|
|
Key Players Covered in the Report
|
GE Healthcare; Abbott Laboratories; Koninklijke Philips NV; Intuitive Surgical Inc.; Medtronic PLC; Olympus Corporation; Smith & Nephew; Stryker Corporation; Siemens Healthineers; and Zimmer Biomet.
|
Canada Minimally Invasive Surgery Devices Market Segment Insights
Robotic assisted surgical systems segment is projected to expand at a considerable CAGR
On the basis of products, the market is classified as handheld instruments, guiding devices, electrosurgical devices, endoscopic devices, laparoscopic devices, robotic assisted surgical systems, ablation devices, laser based devices, and others. The robotic assisted surgical systems segment is projected to expand at a considerable CAGR during the forecast period. Robotic assisted surgical systems attributed to the high efficiency and precision that the surgical robots offer this market.
Gastrointestinal segment is projected to expand at a considerable CAGR
On the basis of applications, the minimally invasive surgery devices market is segregated into aesthetic, cardiovascular, gastrointestinal, gynecological, orthopedic, urological, and others. The gastrointestinal segment is projected to expand at a considerable CAGR during the forecast period. Rising rate of geriatric and pediatric gastroenterological disorders are some of the key factors driving the market growth. Dyspepsia, irritable-bowel syndrome, and constipation are some of the examples of gastrointestinal disorders.
Segments
The Canada minimally invasive surgery devices market has been segmented on the basis of
Products
- Handheld Instruments
- Guiding Devices
- Electrosurgical Devices
- Endoscopic Devices
- Laproscopic Devices
- Robotic Assisted Surgical Systems
- Ablation Devices
- Laser Based Devices
- Others
Applications
- Aesthetic
- Cardiovascular
- Gastrointestinal
- Gynecological
- Orthopedic
- Urological
- Others
Country
Key Players
- GE Healthcare
- Abbott Laboratories
- Koninklijke Philips NV
- Intuitive Surgical Inc.
- Medtronic PLC
- Olympus Corporation
- Smith & Nephew
- Stryker Corporation
- Siemens Healthineers
- Zimmer Biomet.
Competitive Landscape
The market is very competitive in nature owing to the presence of many major players. Some of the major players competing in the Canada minimally invasive surgery devices market are GE Healthcare; Abbott Laboratories; Koninklijke Philips NV; Intuitive Surgical Inc.; Medtronic PLC; Olympus Corporation; Smith & Nephew; Stryker Corporation; Siemens Healthineers; and Zimmer Biomet.
In December 2020, Abbott launched a minimally-invasive heart valve repair device in India to treat mitral regurgitation. It can assist with reestablishing the heart’s ability to pump oxygenated blood more productively and assist with further developing the organization's income.
Request For Customization
Enquiry Before Buying
Speak With Analyst
